Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart A Grossman

Showing results (151-160 of 171) with videos related to

Pageof 18
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 1, 2016
Repeatability of <sup>18</sup>F-FLT PET in a Multicenter Study of Patients with High-Grade GliomaMartin A Lodge, Matthias Holdhoff, Jeffrey P Leal, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 29, 2004
A phase I open-label, dose-escalation, multi-institutional trial of injection with an E1B-Attenuated adenovirus, ONYX-015, into the peritumoral region of recurrent malignant gliomas, in the adjuvant settingE Antonio Chiocca, Khalid M Abbed, Stephen Tatter, et al.
Magnetic Resonance Imaging|June 15, 2023
CEST2022: Amide proton transfer-weighted MRI improves the diagnostic performance of multiparametric non-contrast-enhanced MRI techniques in patients with post-treatment high-grade gliomasQianqi Huang, Jingpu Wu, Nhat Le, et al.
Autophagy|July 4, 2014
A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiformeMyrna R Rosenfeld, Xiaobu Ye, Jeffrey G Supko, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2021
Glioblastoma Clinical Trials: Current Landscape and Opportunities for ImprovementStephen J Bagley, Shawn Kothari, Rifaquat Rahman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2011
It is time to include patients with brain tumors in phase I trials in oncologyPatrick Y Wen, David Schiff, Timothy F Cloughesy, et al.
International Journal of Radiation Oncology, Biology, Physics|February 13, 2016
Lymphocyte-Sparing Effect of Stereotactic Body Radiation Therapy in Patients With Unresectable Pancreatic CancerAaron T Wild, Joseph M Herman, Avani S Dholakia, et al.
Neuro-Oncology|March 12, 2026
Evaluating "Brain Permeability": A Critical Issue for the Development of Therapeutic Agents for Primary and Metastatic Brain TumorsStuart A Grossman, Amy Barone, Roy E Strowd, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2024
Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERTManmeet S Ahluwalia, Ahmad Ozair, Jan Drappatz, et al.
Nature Reviews. Clinical Oncology|December 9, 2024
Leptomeningeal metastatic disease: new frontiers and future directionsAhmad Ozair, Hannah Wilding, Debarati Bhanja, et al.
Pageof 18

Showing results (151-160 of 171) with videos related to

Sort By:
Pageof 18
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 1, 2016
Repeatability of <sup>18</sup>F-FLT PET in a Multicenter Study of Patients with High-Grade GliomaMartin A Lodge, Matthias Holdhoff, Jeffrey P Leal, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 29, 2004
A phase I open-label, dose-escalation, multi-institutional trial of injection with an E1B-Attenuated adenovirus, ONYX-015, into the peritumoral region of recurrent malignant gliomas, in the adjuvant settingE Antonio Chiocca, Khalid M Abbed, Stephen Tatter, et al.
Magnetic Resonance Imaging|June 15, 2023
CEST2022: Amide proton transfer-weighted MRI improves the diagnostic performance of multiparametric non-contrast-enhanced MRI techniques in patients with post-treatment high-grade gliomasQianqi Huang, Jingpu Wu, Nhat Le, et al.
Autophagy|July 4, 2014
A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiformeMyrna R Rosenfeld, Xiaobu Ye, Jeffrey G Supko, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2021
Glioblastoma Clinical Trials: Current Landscape and Opportunities for ImprovementStephen J Bagley, Shawn Kothari, Rifaquat Rahman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2011
It is time to include patients with brain tumors in phase I trials in oncologyPatrick Y Wen, David Schiff, Timothy F Cloughesy, et al.
International Journal of Radiation Oncology, Biology, Physics|February 13, 2016
Lymphocyte-Sparing Effect of Stereotactic Body Radiation Therapy in Patients With Unresectable Pancreatic CancerAaron T Wild, Joseph M Herman, Avani S Dholakia, et al.
Neuro-Oncology|March 12, 2026
Evaluating "Brain Permeability": A Critical Issue for the Development of Therapeutic Agents for Primary and Metastatic Brain TumorsStuart A Grossman, Amy Barone, Roy E Strowd, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2024
Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERTManmeet S Ahluwalia, Ahmad Ozair, Jan Drappatz, et al.
Nature Reviews. Clinical Oncology|December 9, 2024
Leptomeningeal metastatic disease: new frontiers and future directionsAhmad Ozair, Hannah Wilding, Debarati Bhanja, et al.
Pageof 18